SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007993
Filing Date
2004-03-15
Accepted
2004-03-15 16:14:56
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2129731z10-k.htm 10-K 816070
3 EXHIBIT 10.35 a2129731zex-10_35.txt EX-10.35 226219
4 EXHIBIT 21 a2129731zex-21.txt EX-21 728
5 EXHIBIT 23.1 a2129731zex-23_1.txt EX-23.1 682
6 EXHIBIT 31.1 a2129731zex-31_1.txt EX-31.1 3760
7 EXHIBIT 31.2 a2129731zex-31_2.txt EX-31.2 3804
8 EXHIBIT 32.1 a2129731zex-32_1.txt EX-32.1 1631
  Complete submission text file 0001047469-04-007993.txt   1054992
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 04669736
SIC: 2834 Pharmaceutical Preparations